title: Influence of frame size and zeranol on growth, compositional growth and plasma hormone characteristics.
abstract: A 2 X 2 factorially arranged trial was conducted to compare effects of implant (zeranol) and frame size on weight and compositional gain, and plasma hormone concentrations. Angus, Charolais X Hereford and Hereford X Angus yearling steers (34 steers averaging 270 kg body weight) were randomly assigned to treatments of small (SF) vs large frame (LF) and implant (I) vs no implant (NI). Steers were implanted at 0 and 97 d and individually fed an 81% whole shelled corn and 11.5% corn silage-based diet (dry basis) for a 175-d period. Shrunk weights and body measurements for frame size determination were taken initially and at approximately 28-d intervals; blood was collected via venipuncture at 14-d intervals for analyses of insulin (IN), triiodothyronine (T3), thyroxine (T4) and glucose concentrations. Steers were also counted in a whole body counter for measurement of 40K content and prediction of whole body protein and fat. The I steers showed an improvement (P less than .05) in daily gain regardless of frame size for the total trial. The I LF steers required 18% more dry matter to attain higher daily gain for 97 to 175 d; I steers were more efficient (P less than .05) at converting dry matter to gain during 0 to 97 d and 0 to 175 d. Daily fat deposition was increased (P less than .05) in I steers, while protein deposition was not affected by I. Plasma IN concentrations were numerically elevated (P less than .10) in I steers regardless of frame size, during the initial 97 d. Implant did not influence (P greater than .10) plasma T3, T4 and glucose concentrations regardless of frame size. Steers responded differently to zeranol implant over time regarding plasma T4 concentrations (P less than .003). Steers differing in frame size responded similarly in rate of gain, in feed conversion and in patterns of plasma insulin concentrations to zeranol implants.
authors.affiliation: University of Missouri, Columbia 65211.
authors.forename: J E
authors.initials: JE
authors.lastname: Williams
authors.forename: S J
authors.initials: SJ
authors.lastname: Miller
authors.forename: T A
authors.initials: TA
authors.lastname: Mollett
authors.forename: S E
authors.initials: SE
authors.lastname: Grebing
authors.forename: D K
authors.initials: DK
authors.lastname: Bowman
authors.forename: M R
authors.initials: MR
authors.lastname: Ellersieck
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D001823:Body Composition / Q000187:drug effects*; D001824:Body Constitution; D002417:Cattle / Q000254:growth & development*; D007328:Insulin / Q000097:blood*; D008297:Male; D012118:Resorcinols / Q000494:pharmacology*; D013963:Thyroid Hormones / Q000097:blood*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood; D015029:Zeranol / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D012118:Resorcinols; D013963:Thyroid Hormones; D014284:Triiodothyronine; D015029:Zeranol; D013974:Thyroxine